Source: Health Canada shortage reports · Updated Aug 25, 2026
Propafenone has no current shortage reported in Canada. It has been in shortage before; the history is below.
An antiarrhythmic medicine used to treat irregular heart rhythms.
Products affected
0 / 12
Reports on file
46
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Aug 20, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Feb 13, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Feb 13, 2026 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Jul 3, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Jul 2, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Jun 10, 2025 · Disruption of the manufacture of the drug.
Resolved
RYTHMOL
300MG · TABLET · BGP PHARMA ULC
DIN 00603716 · ended Apr 11, 2025 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Mar 13, 2025 · Disruption of the manufacture of the drug.
Avoided
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Nov 21, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
300MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457164 · ended Nov 26, 2024 · Disruption of the manufacture of the drug.
Resolved
MYLAN-PROPAFENONE
150MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02457172 · ended Nov 21, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-PROPAFENONE
150MG · TABLET · APOTEX INC
DIN 02243324 · ended Apr 25, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 46 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Propafenone. Health Canada has 46 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Propafenone is classified under “ANTIARRHYTHMICS, CLASS I AND III” (ATC C01BC).
Recent changes
Aug 25, 2026
Shortage resolved
Aug 18, 2026
Estimated end date moved earlier : Sep 8, 2026 → Aug 19, 2026
Aug 10, 2026
Status changed
Aug 5, 2026
Estimated end date pushed back : Aug 25, 2026 → Sep 8, 2026
Jul 13, 2026
New report filed
Common questions
What is Propafenone used for?
An antiarrhythmic medicine used to treat irregular heart rhythms.
When will Propafenone be back in stock in Canada?
Propafenone has no active shortage; supply is normal per Health Canada reports.
Why is Propafenone in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.